Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2012
11/29/2012WO2012161372A1 Double-target antibody fused with a peptide and use of same
11/29/2012WO2012161352A1 Reic-expressing adenovirus vector
11/29/2012WO2012161250A1 Alpha-glucosidase, method for production thereof, application thereof, gingerol glycoside, method for production thereof, and application thereof
11/29/2012WO2012161227A1 Nucleic acid construct, nucleic acid-protein complex, and use thereof
11/29/2012WO2012161196A1 LIPOSOME CONTAINING shRNA MOLECULE FOR THYMIDYLATE SYNTHASE, AND USE FOR SAME
11/29/2012WO2012161144A1 Ribozyme for identifying modification on rna sequence and rna cleavage method using same
11/29/2012WO2012161124A1 Composition containing micro rna or expression system thereof
11/29/2012WO2012161117A1 Primer set for identification of cytomegalovirus genome
11/29/2012WO2012161024A1 Method for producing recombinant protein, and method for introducing protein
11/29/2012WO2012160990A1 Igf-1r-binding peptide
11/29/2012WO2012160528A2 Development of phytophthora resistant potato with increased yield
11/29/2012WO2012160517A1 Bilirubin oxidase from magnaporthe oryzae and applications thereof
11/29/2012WO2012160215A1 Soluble protein cd5 or cd6 for the treatment of cancer or tumor or for use as an adjuvant
11/29/2012WO2012160184A1 Immunostimulatory oligodeoxynucleotides
11/29/2012WO2012160183A1 Immunostimulatory oligodeoxynucleotides
11/29/2012WO2012160130A1 Erk inhibitors for use in treating spinal muscular atrophy
11/29/2012WO2012160097A1 Bi-directional cytosine deaminase-encoding selection marker
11/29/2012WO2012160093A1 Simultaneous site-specific integrations of multiple gene-copies in filamentous fungi
11/29/2012WO2012159891A1 Endosperm-specific plant promoters and uses therefor
11/29/2012WO2012159571A1 Method for improving sugar utilization rate of clostridium acetobutylicum in mixed sugar fermentation
11/29/2012WO2012159564A1 High throughput methylation detection method
11/29/2012WO2012159562A1 Truncated human papillomavirus type 33 protein l1
11/29/2012WO2012159550A1 Fgfr-fc fusion protein and use thereof
11/29/2012WO2012159548A1 Fusion protein for antagonizing angiogenesis inducible factors and uses thereof
11/29/2012WO2012159522A1 Canine influenza recombinant virus, preparation method therefor and application thereof
11/29/2012WO2012159216A1 Bone tissue regenerating peptides
11/29/2012WO2012159196A1 Plants having enhanced abiotic stress resistance
11/29/2012WO2012140516A3 Non human animal model for ulcerative colitis and its main complications
11/29/2012WO2012139081A3 Methods for treating conditions associated with masp-2 dependent complement activation
11/29/2012WO2012139046A3 Signal amplification methods for the imaging of protein synthesis and neurotransmitter transport
11/29/2012WO2012135731A3 Alcohol production from recombinant microorganisms
11/29/2012WO2012134063A3 Primer for detecting pathogenic bacteria of oral bacterial infectious diseases, and use thereof
11/29/2012WO2012118900A3 Surface display of cellulolytic enzymes and enzyme complexes on gram-positive microorganisms
11/29/2012WO2012116076A3 Constructs that allow for detection and quantitation of membrane proteins
11/29/2012WO2012108740A3 Mutant microorganism with enhanced sugar utilization and methods for preparing the same
11/29/2012WO2012102521A3 Human anti-cd23 fab antibody and a pharmaceutical composition for treating tumours comprising same
11/29/2012WO2012093833A3 Genome engineering via designed tal effector nucleases
11/29/2012WO2012078741A3 Novel fungal esterases
11/29/2012WO2012020307A3 Therapeutic uses of microvesicles and related micrornas
11/29/2012WO2006091470A8 Improved halohydrin dehalogenases and related polynucleotides
11/29/2012US20120304337 Endotoxins having nematocidal activity and methods of use thereof
11/29/2012US20120304336 Chloroplast transit peptides and methods of their use
11/29/2012US20120304335 Mutant hydroxyphenylpyruvate dioxygenase polypeptides and methods of use
11/29/2012US20120304333 Cotton Variety FM 2484B2F
11/29/2012US20120304331 Herbicide tolerant soybean plants and methods for identifying same
11/29/2012US20120304330 Elite event ee-gm3 and methods and kits for identifying such event in biological samples
11/29/2012US20120304323 Maternally induced sterility in animals
11/29/2012US20120304321 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
11/29/2012US20120304320 Transgenic biosensors
11/29/2012US20120304318 Cancer diagnosis and treatment
11/29/2012US20120304317 Transgenic rodent expressing truncated disc1
11/29/2012US20120303472 Methods for placing, accepting, and filling orders for products and services
11/29/2012US20120302777 Glycerol 3-phosphate acyltransferase homologue and use thereof
11/29/2012US20120302741 Non-invasive detection of fetal genetic traits
11/29/2012US20120302739 Biological products
11/29/2012US20120302738 Recombinant antibody vector
11/29/2012US20120302732 Chimeric immunoreceptor useful in treating human cancers
11/29/2012US20120302626 Microrna and use thereof in identification of b cell malignancies
11/29/2012US20120302625 Supercoiled minicircle dna for gene therapy applications
11/29/2012US20120302511 Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer
11/29/2012US20120302510 Histone deacetylases, and uses related thereto
11/29/2012US20120302509 Compositions and methods to prevent cancer with cupredoxins
11/29/2012US20120302492 Antibody Mimetic Scaffolds
11/29/2012US20120302464 Methods for producing recombinant proteins
11/29/2012US20120302463 Focused libraries of genetic packages
11/29/2012US20120302461 Gfp mutagenesis amplification: use of a fluorescence-antibiotic resistance fusion dual reporter construct to provide quantitative and highly sensitive detection of mutations
11/29/2012US20120302452 Comparative ligand mapping from mhc class i positive cells
11/29/2012US20120301965 Cell programming
11/29/2012US20120301964 Methods and compositions for genetically engineering clostridia species
11/29/2012US20120301962 Vitronectin-derived cell culture substrate and uses thereof
11/29/2012US20120301959 Cryoconserved Mature Dendritic Cells
11/29/2012US20120301955 Modified messenger RNA stabilizing sequences for expressing genes in bacterial cells
11/29/2012US20120301945 Protease screening methods and proteases identified thereby
11/29/2012US20120301944 Bgl6 beta-glucosidase and nucleic acids encoding the same
11/29/2012US20120301936 Recombinant mutant microorganisms having increased ability to produce alcohols and method of producing alcohols using the same
11/29/2012US20120301930 Bio-engineered multi-enzyme complexes comprising xylanases and uses thereof
11/29/2012US20120301927 Production Of Maltotetraose Syrup Using A Pseudomonas Saccharophila Maltotetraohydrolase Variant
11/29/2012US20120301922 Novel p. pastoris pastoris promoters, and the use thereof to direct expression of proteins in yeast, preferably using a haploid mating strategy
11/29/2012US20120301921 Compositions and methods of treating disease with fgfr fusion proteins
11/29/2012US20120301919 Ires mediated multicistronic vectors
11/29/2012US20120301918 Method for producing alpha-l-aspartyl-l-phenylalanine-beta-ester and method for producing alpha-l-aspartyl-l-phenylalanine-alpha-methyl ester
11/29/2012US20120301912 Methods, compositions and kits for assaying mitochondrial function
11/29/2012US20120301899 Use of novel markers of pluripotent stem cells
11/29/2012US20120301873 Human long pentraxin 3 expression system and uses thereof
11/29/2012US20120301871 Comparative ligand mapping from mhc positive cells
11/29/2012US20120301578 Enzymes
11/29/2012US20120301575 Bacterium
11/29/2012US20120301497 Plasmodium vivax Hybrid Circumsporozoite Protein and Vaccine
11/29/2012US20120301496 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
11/29/2012US20120301495 Antigen peptide and use thereof
11/29/2012US20120301493 Applications of the protein muns and the derivates thereof
11/29/2012US20120301489 Jagged-Binding Agents and Uses Thereof
11/29/2012US20120301488 Anti-cd40 antibodies and methods of use
11/29/2012US20120301485 Juvenile Hemochromatosis Gene (HFE2A) Cleavage Products and Uses Thereof
11/29/2012US20120301479 Hendra virus recombinant compositions and uses thereof
11/29/2012US20120301474 Compositions and methods for immunization against drug resistant acinetobacter baumannii
11/29/2012US20120301472 Reagents and treatment methods for autoimmune diseases
11/29/2012US20120301469 amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
11/29/2012US20120301462 Compounds
11/29/2012US20120301461 1d05 pcsk9 antagonists
1 ... 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 ... 4023